IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J. J.
Right arrow Articles by Chung, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. J.
Right arrow Articles by Chung, H.
(Investigative Ophthalmology and Visual Science. 2002;43:3117-3124.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Effect of 2'-Benzoyl-oxycinnamaldehyde on RPE Cells In Vitro and in an Experimental Proliferative Vitreoretinopathy Model

Jae Jun Lee1,2, Jong Kuk Park2,3,4, Yun-Taik Kim3, Byoung-Mog Kwon5, Shin Goo Kang6, Young Do Yoo4,7, Young Suk Yu8,9 and Hum Chung8,9

1 From the Department of Ophthalmology, St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea; the 3 Department of Life Science, Sogang University, Seoul, Korea; the 5 Korea Research Institute of Bioscience and Biotechnology, Yusong, Taejon; the 6 Department of Ophthalmology, Eulji University School of Medicine, Seoul, Korea; the 7 Department of Internal Medicine and the 4 Genomic Research Center for Lung and Breast/Ovarian Cancers, Korea University College of Medicine, Seoul, Korea; the 8 Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea; and the 9 Seoul National University Hospital Clinical Research Institute, Seoul, Korea.

PURPOSE. To investigate whether 2'-benzoyl-oxycinnamaldehyde (BCA) induces apoptosis in human retinal pigment epithelial (hRPE) cells and has an antiproliferative effect in a proliferative vitreoretinopathy (PVR) model in the rabbit.

METHODS. Fifty percent growth inhibition doses of hRPE cells at 50%, 75%, and 100% confluence were determined by MTT assay. Apoptosis in hRPE cells induced by BCA was shown by DAPI staining. Expression of p53, p21, Bcl-2, GADD45, cyclin D, phospho-MAP kinase, cdk2, and Akt1 at various concentrations of BCA in cultured hRPE cells was examined by immunoblot analysis. In the efficacy study, 2.0 x 105 rabbit RPE cells were injected into the vitreous cavity after gas compression, and the eyes subsequently received either sham injections or 600 µM BCA. Fundus examination was performed before and 1, 7, 14, 21, and 28 days after BCA injection. The toxicity studies were conducted by the same protocol as used for the efficacy evaluation but without the RPE cell injection. Simultaneous electroretinograms were recorded on days 1, 7, 14, 21, and 28 after exposure to the drug.

RESULTS. BCA treatment induced apoptosis in hRPE cells. Furthermore, an increase in p53 expression, phosphorylation of Bcl-2, and downregulation of Akt1 expression were observed in BCA-induced apoptotic cells. BCA effectively prevented the proliferation of rabbit RPE cells in the experimental PVR model. BCA exhibited a wide safety margin, showing no evidence of causing retinal toxicity, even at the 600-µM concentration.

CONCLUSIONS. The results of this study suggest that BCA effectively inhibits proliferation of RPE cells and has a very wide safety margin, indicating a potential therapeutic usefulness in treating PVR.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology